Logan Capital Management Inc. trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 8.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 21,178 shares of the healthcare conglomerate’s stock after selling 2,042 shares during the quarter. Logan Capital Management Inc.’s holdings in UnitedHealth Group were worth $10,713,000 at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of the stock. NewSquare Capital LLC bought a new stake in UnitedHealth Group during the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at $28,000. Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group during the 4th quarter valued at about $30,000. Finally, AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth about $30,000. 87.86% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of research analysts recently weighed in on UNH shares. HSBC reissued a “hold” rating and issued a $490.00 target price on shares of UnitedHealth Group in a report on Tuesday, April 22nd. JPMorgan Chase & Co. lowered their target price on shares of UnitedHealth Group from $652.00 to $525.00 and set an “overweight” rating for the company in a report on Thursday, April 24th. Truist Financial dropped their price objective on UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating for the company in a report on Monday, April 21st. Raymond James reaffirmed a “strong-buy” rating and issued a $540.00 price target (down previously from $635.00) on shares of UnitedHealth Group in a research note on Monday, April 21st. Finally, Oppenheimer decreased their price target on shares of UnitedHealth Group from $640.00 to $600.00 and set an “outperform” rating for the company in a research note on Monday, April 21st. Four investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $596.86.
UnitedHealth Group Trading Down 1.3%
UNH opened at $380.72 on Monday. UnitedHealth Group Incorporated has a 1-year low of $378.54 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market capitalization of $345.37 billion, a price-to-earnings ratio of 24.56, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company’s 50 day simple moving average is $488.01 and its two-hundred day simple moving average is $522.04.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the business earned $6.91 earnings per share. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.21%. UnitedHealth Group’s dividend payout ratio is currently 35.18%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- What Does Downgrade Mean in Investing?
- 3 ETFs Beating the S&P 500 as Volatility Rises
- Short Selling – The Pros and Cons
- Constellation Powers Up With Reinforced AI Data Center Strategy
- How to Choose Top Rated Stocks
- Top Analyst-Rated Healthcare Stocks to Watch Now
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.